In this study, we generated a deletion mutant in the type 1 RH (RHΔ) strain and tested the protective efficacies of vaccination using RHΔ tachyzoites against acute, chronic, and congenital infections in Kunming mice. Mice vaccinated with RHΔ mounted a strong humoral and cellular response as shown by elevated levels of anti–specific IgG, IL-2, IL-12, IFN-γ, and IL-10. All RHΔ-vaccinated mice survived a lethal challenge with 1 × 10 tachyzoites of type 1 RH or ToxoDB#9 (PYS or TgC7) strain as well as 100 cysts or oocysts of Prugniuad strain. All mock-vaccinated plus infected mice have died. Vaccination also protected against cyst- or oocyst-caused chronic infection, reduced vertical transmission caused by oocysts, increased litter size, and maintained body weight of pups born to dams challenged with 10 oocysts on day 5 of gestation. In contrast, all mock-vaccinated plus oocysts-infected dams had aborted, and no fetus has survived. Vaccinated dams remained healthy postinfection, and their brain cyst burden was significantly reduced compared with mock-vaccinated dams infected with oocysts. In vivo depletion of CD4 T cells, CD8 T cells, and B cells revealed that CD8 T cells are involved in the protection of mice against infection. Additionally, adoptive transfer of CD8 T cells from RHΔ-vaccinated mice significantly enhanced the survival of naive mice infected with the pathogenic strain. Together, these data reaffirm the importance of CD8 T cell responses in future vaccine design for toxoplasmosis and present gene as a promising vaccine candidate.Copyright © 2020 by The American Association of Immunologists, Inc.
August 6, 2020
Intermittent REM sleep deprivation attenuates the development of morphine tolerance and dependence in male rats.
February 18, 2021
Five-Year Outcome of Laparoscopic Fundoplication in Pediatric GERD Patients: a Multicenter, Prospective Cohort Study.
July 27, 2020
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- CROI 2020Every year, CROI hosts some of the world's leading experts in HIV research, who come to present exciting new data and drive forward the field of HIV/AIDS research. This year, due to COVID-19, CROI held their meeting virtually.